Abstract: The disclosure relates to a process for the dimerization of conjugated diene compounds by a heterogeneous catalytic process using a supported palladium catalyst in the presence of at least one palladium activator and at least one palladium coordinating agent.

Abstract: A subject of the present invention is a compound having the general formula (I): a pharmaceutically acceptable salt thereof or a tautomeric form thereof, wherein A, B3, B4, B5, Y, X, B1 and B2 are as defined in any one of claims 1 to 10. Another subject of the invention is the compound as defined above for use as a medicament, in particular for preventing and/or treating inflammation and inflammatory diseases, immune and auto-immune diseases, pain related diseases, genetic diseases and/or cancer.

Abstract: An object is to provide a component for molecular Computing and a method of molecular Computing. A component for molecular Computing, the component comprising: a microsphere including pores, at least some of which are open on a surface of the microsphere, and a plurality of modules grafted on the microsphere wherein each of the modules is a continuous sequence of nucleic acid base.

Abstract: An optically transparent electromagnetic shield assembly comprising an electrical connection device with variable electrical resistance. The electrical connection device electrically connects a conductive two-dimensional structure, which covers a transparent substrate, to a shell portion which is electrically conductive. The resistance of the connection device can be adjusted, either initially for a detection system for which the shield assembly is intended or in real time while the shield assembly is in use, according to an RF radiation intensity.

Abstract: The invention relates to a method for clustering nodes of a network, the network comprising nodes associated with message edges of text data, the method comprising an initialization step of determination of a first initial clustering of the nodes, and a step of iterative inference of a generative model of text documents. Edges are modeled with a Stochastic Block Model (SBM) and the sets of documents between and within clusters are modeled according to a generative model of documents. The inference step comprises iteratively modelling the text documents and the underlying topics of their textual content, and updating the clustering as a function of the modelling, until a convergence criterion is fulfilled and an optimized clustering and corresponding optimized values of the parameters of the models are output.

Abstract: The present invention relates to a process for texturing surfaces providing the latter with superhydrophobic, superoleophobic, superhydrophilic or even superoleophilic properties. This process comprises i) a step of texturing the surface (via the deposition of nanoparticles of different sizes); ii) a step of curing the surface thus textured (with a curing agent); and, optionally, iii) a step of modifying the properties of the surface with perfluorinated (and therefore hydrophobic) molecules. This process is suitable, inter alia, for treating transparent and/or heat-sensitive materials and surfaces. Specifically, none of the steps of the process use a temperature higher than 100° C. Thus, the process of the invention is particularly suitable for treating transparent surfaces composed of non-mineral materials, such as polycarbonate for example, as it will affect neither their transparency nor their optical properties.

Abstract: The invention relates to a method for hydrosilylating an unsaturated compound comprising at least one ketone function, one aldehyde function, one alkene function and/or one alkyne function, with a compound comprising at least one hydrogenosilyl function, using an organic germanium catalyst.

Abstract: The present invention concerns a method for labeling specifically living bacteria of a given category of bacteria in a sample comprising bacteria, the method comprising the steps of: a) incubating said bacteria of said sample with at least one analog of a monosaccharide compound, said monosaccharide being an endogenous monosaccharide residue of glycans of the outer membrane of such given category of bacteria, the said endogenous monosaccharide residue comprising an ulosonic acid or ulosonate salt residue, the said analog of a monosaccharide compound being a modified monosaccharide substituted at a given position by a first reactive chemical group capable to react with a second reactive group of a labeling molecule, the said given position being preferably a position which comprises a free group in the said endogenous monosaccharide residue incorporated within said glycans of the outer membrane of the bacteria, b) contacting said bacteria with a said labeling molecule comprising a said second reactive group

Abstract: A synthetic antiferromagnetic layer includes a first ferromagnetic layer containing an amorphizing element, the first ferromagnetic layer having a first structural symmetry; a second ferromagnetic layer having a second structural symmetry; wherein the first and the second ferromagnetic layers are antiferromagnetically coupled by a trifunctional non-magnetic multi-layered structure, the antiferromagnetic coupling being an Ruderman-Kittel-Kasuya-Yosida (RKKY) coupling, the non-magnetic multi-layered structure including at least two non-magnetic layers, the non-magnetic multilayered structure being at least partially nano-crystalline or amorphous in order to ensure a structural transition between the first ferromagnetic layer having the first structural symmetry and the second ferromagnetic layer having the second structural symmetry, the non-magnetic multilayered structure being adapted to absorb at least part of the amorphizing element out of the first ferromagnetic layer in contact with the non-magnetic multi

Abstract: The invention relates to compounds which are inhibitors of the polymerization of tubulin, to the methods for the production thereof, and to the uses of same.

Abstract: An object is to provide a method of eliminating background amplification in detection of rare nucleic acids based on isothermal amplification. The method comprising steps of: preparing a mixture including solution and enzymes, and adding a first and a second template into the mixture, wherein the first template is an amplification template, and the second template is a leak absorption template. Methods to use this approach for multiplexed, ultrasensitive and ultra-specific detection of nucleic acids are presented.

Abstract: The present invention relates to a new lithium-doped Pernigraniline-based material, a method for the preparation thereof, its use in various applications, an electrode comprising said lithium-doped Pernigraniline-based material and its preparation method, a membrane comprising said lithium-doped Pernigraniline-based material and its preparation method, and an electrochemical storage system comprising said electrode.

Abstract: The disclosure relates to a selective head-to-head dimerization of conjugated diene compounds by a catalytic process in a reaction medium without solvent or with solvent comprising hydrocarbons, in the presence of a specific additive of the phenol type.

Abstract: A sacrificial positive active material for a lithium-ion electrochemical element which is a compound of formula (Li2O)x (MnO2)y(MnO)z(MOa)t in which: x+y+z+t=1; 1?x?y?0; 0.97?x?0.6; y?0.45; x ?0.17; y?0; y+z>0; t?0; 1?a<3. M is selected from the group consisting of Fe, Co, Ni, B, Al, Ti, Si, V, Mo, Zr and a mixture thereof.

Abstract: The present invention concerns, in particular, a method for obtaining a product with magnetocaloric effect from a single piece of material having a magnetic phase transition, the method comprising irradiation of at least one part of the material with ions, the irradiation being carried out with a suitable flux so that, after the irradiation, the material has various magnetic phase transition temperatures in the various parts of the material.

Abstract: The invention relates to a process for manufacturing a laminated material (S) comprising a fibrillated cellulose layer, characterized in that it comprises the following steps: (a) depositing a suspension (1) of fibrillated cellulose on a filtration membrane (2) and draining the suspension through that membrane so as to form a wet layer of fibrillated cellulose (A) having a dryness, that is to say a ratio between the mass of dry matter and the total mass of the fibrillated cellulose layer, of between 5% and 18%; (b) transferring the wet layer (A) under pressure to an at least partially hydrophilic surface of a substrate (B), so as to form the laminated material (S); (c) drying the laminated material. The invention also relates to a device for implementing the process.

Abstract: The invention relates to a novel use of ultrafine nanoparticles, of use as a diagnostic, therapeutic or theranostic agent, characterized by their mode of administration via the airways. The invention is also directed toward the applications which follow from this novel mode of administration, in particular for imaging the lungs, and the diagnosis or prognosis of pathological pulmonary conditions. In the therapeutic field, the applications envisioned are those of radiosensitizing or radioactive agents for radiotherapy (and optionally curietherapy), or for neutron therapy, or of agents for PDT (photodynamic therapy), in particular for the treatment of lung tumors.

Abstract: The invention relates to the use of a composition from a plant extract of Withania somnifera, to treat or prevent amyloid-related diseases, including Alzheimer disease.

Abstract: The invention relates to a composition containing a Withania somnifera extract, obtained by fermentation by incubating the Withania somnifera extract with a filamentous fungus of the Beauveria genus. The composition can be used to treat or prevent ?-synucleinopathies in a subject.

Abstract: The present invention concerns an in vitro process for diagnosing joint disease in a mammal and/or determining the type of joint disease and/or determining the stage of said disease and/or predicting the course of said disease, comprising the following steps: a) depositing a drop of a synovial fluid sample from said mammal onto a flat substrate made of an inorganic material, such as glass; b) drying the drop deposited in step a); c) measuring at least one parameter indicative of the morphological features of the drop dried in step b), whereby a value for said parameter is obtained, and d) comparing each value measured in step c) with a reference value representative of a reference synovial fluid, characterized in that said parameter is selected from (i) the maximum height (H) of the bead formed on the surface of the drop, (ii) the area of the drop and (iii) the surface profile (Z) of the drop.